API

4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. It invests in, supports, and grows early-stage companies developing treatments in areas of high unmet medical need. The firm's team comprises leading advanced therapy scientists and experienced life science investors.

Afore Capital is a $300M fund investing in pre-traction companies. They focus on what can go right and work quickly to make decisions. They consider themselves a founder's SWAT team, providing support and asking tough questions.

ATX Venture Partners is an early-stage venture capital firm investing across North America, primarily in disruptive B2B software, APIs, marketplaces, and applications. They focus on providing capital and a value-add platform to help portfolio companies accelerate growth.